source
- Trade group warns stalled biosimilar development could forfeit billions in savingsA trade association that represents generic drug makers and biosimilar developers released a new report warning that progress on biosimilar products has slowed. The group says the slowdown threaten…
- Takeda R&D chief Andy Plump to retire in 2027 as Novo Nordisk names Alex Hoffman global research headTakeda announced that its head of research and development, Andy Plump, will step down in June 2027. Plump, who joined Takeda from Sanofi in 2015 and has led R&D since December 2018, will retire af…